High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma
Wenjie Zheng,1,2,* Junling Yang,2,* Zhizhen Dong,3,* Li Wang,1 Miao Fang,1 Wei Wu,2 Dengfu Yao,1,2 Min Yao1 1Medical School of Nantong University, Nantong 226001, Jiangsu, China; 2Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu, China; 3Depart...
Main Authors: | Zheng W, Yang J, Dong Z, Wang L, Fang M, Wu W, Yao D, Yao M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-11-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/high-mobility-group-box-3-as-an-emerging-biomarker-in-diagnosis-and-pr-peer-reviewed-article-CMAR |
Similar Items
-
Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
by: Xiaoyi Hu, et al.
Published: (2020-11-01) -
In-depth characterization of the biomarkers based on tumor-infiltrated immune cells reveals implications for diagnosis and prognosis in hepatocellular carcinoma
by: Wenbiao Chen, et al.
Published: (2020-01-01) -
Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
by: Xiaoyi Hu, et al.
Published: (2020-09-01) -
Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma
by: Li L, et al.
Published: (2014-05-01) -
Hsa_circ_0003998 may be used as a new biomarker for the diagnosis and prognosis of hepatocellular carcinoma
by: Qiao GL, et al.
Published: (2019-07-01)